Literature DB >> 1379911

Topical corticosteroids. Which drug and when?

B Giannotti1, N Pimpinelli.   

Abstract

A number of factors have to be taken into account when dealing with the treatment of skin diseases with topical corticosteroids, including disease type and phase, potency of the drug, safety, site to be treated, age of the patient, and drug formulation. Concerning the specific indications for topical corticosteroid treatment, we can distinguish skin diseases in which: (a) topical corticosteroids are the treatment of choice; (b) topical corticosteroids are useful as alternative and/or adjuvant treatment; (c) the proposed use of topical corticosteroids has to be confirmed as useful; and (d) topical corticosteroids can be used as a symptomatic treatment. Within these groups, the treatment schedule has to be adjusted according to the above mentioned general factors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379911     DOI: 10.2165/00003495-199244010-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  36 in total

1.  Adverse effects of topical corticosteroids.

Authors:  G E Piérard; C Piérard-Franchimont; T Ben Mosbah; J Arrese Estrada
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1989

2.  The safety of halobetasol 0.05% ointment in the treatment of psoriasis.

Authors:  W A Watson; R E Kalb; S B Siskin; J P Freer; L Krochmal
Journal:  Pharmacotherapy       Date:  1990       Impact factor: 4.705

Review 3.  Treatment of cutaneous lesions in patients with lupus erythematosus.

Authors:  J P Callen
Journal:  Dermatol Clin       Date:  1990-04       Impact factor: 3.478

Review 4.  Current treatment guidelines for topical corticosteroids.

Authors:  B Giannotti
Journal:  Drugs       Date:  1988       Impact factor: 9.546

5.  Do topical corticosteroids modulate skin irritation in human beings? Assessment by transepidermal water loss and visual scoring.

Authors:  P G van der Valk; H I Maibach
Journal:  J Am Acad Dermatol       Date:  1989-09       Impact factor: 11.527

6.  Hydrocortisone: an important cutaneous allergen.

Authors:  S M Wilkinson; P H Cartwright; J S English
Journal:  Lancet       Date:  1991-03-30       Impact factor: 79.321

7.  Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function.

Authors:  H I Katz; N T Hien; S E Prawer; L I Mastbaum; J J Mooney; C R Samson
Journal:  J Am Acad Dermatol       Date:  1987-04       Impact factor: 11.527

8.  Treatment of bullous pemphigoid with topical clobetasol propionate.

Authors:  W Westerhof
Journal:  J Am Acad Dermatol       Date:  1989-03       Impact factor: 11.527

9.  Steroid-induced dermal atrophy. Investigations on discontinuous application.

Authors:  D Lubach; A Bensmann; U Bornemann
Journal:  Dermatologica       Date:  1989

10.  Topical corticosteroids for skin disorders in infants and children.

Authors:  J Harper
Journal:  Drugs       Date:  1988       Impact factor: 9.546

View more
  4 in total

Review 1.  Topical corticosteroids: back to basics.

Authors:  N P Lee; E R Arriola
Journal:  West J Med       Date:  1999 Nov-Dec

2.  Extraintestinal Complications of Inflammatory Bowel Disease.

Authors:  Ad A. van Bodegraven; Ben A. C. Dijkmans; Paul Lips; Tom J. Stoof; A. Salvador Peña; Stephan G. M. Meuwissen
Journal:  Curr Treat Options Gastroenterol       Date:  2001-06

Review 3.  Topical corticosteroids and unwanted local effects. Improving the benefit/risk ratio.

Authors:  M Mori; N Pimpinelli; B Giannotti
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

4.  A Rapid and Simple TLC-Densitometric Method for Assay of Clobetasol Propionate in Topical Solution.

Authors:  Malgorzata Dolowy; Violetta Kozik; Andrzej Bak; Josef Jampilek; Krzysztof Barbusinski; Maciej Thomas; Alina Pyka-Pajak
Journal:  Molecules       Date:  2017-11-03       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.